Senate health committee ranking Democrat Patty Murray (WA) said she is considering measures to deal with drug prices as part of the panel's upcoming medical product innovation bill, and Republican lobbyist and congressional aide sources say they doubt key Democrats will vote for a pro-drug industry innovation bill unless drug-price measures are included, as the leading two Democratic presidential candidates are criticizing pharmaceutical price increases. “We’re working on it,” Murray said in response to a question about whether the upcoming...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.